Global Innovative Platforms GIPL
OTC GIPL
$0.50 +0.00 (+0.00%)
At close: Sep 8, 2026 · 4:00 PM EDT

Global Innovative Platforms (GIPL) Cash from Operations (2020 - 2026)

Global Innovative Platforms' (GIPL) quarterly Cash from Operations came in at -$133565.0 in Q2 2026, up 27.52% year-over-year from -$104742.2 in Q2 2025, and down 118.65% quarter-over-quarter from $716175.0 in Q1 2026.

Analysis

Global Innovative Platforms (GIPL) Cash from Operations (2020 - 2026) Analysis & Trends

Global Innovative Platforms has disclosed Cash from Operations across 7 years of filings, most recently posting -$133565.0 for Q2 2026.

  • In Q2 2026, Cash from Operations rose 27.52% year-over-year to -$133565.0; the TTM figure through Jun 2026 stood at -$710926.0 (up 15.76% YoY), while the FY2025 annual figure was -$936443.0, down 149.26% from the prior year.
  • Cash from Operations came in at -$133565.0 for Q2 2026 at Global Innovative Platforms, down from $716175.0 in the prior quarter.
  • In the past five years, Cash from Operations ranged from a high of $716175.0 in Q1 2026 to a low of -$852972.0 in Q4 2025.
  • Average Cash from Operations over 5 years is -$106887.9, with a median of -$61589.0 recorded in 2023.
  • Year-over-year, Cash from Operations soared 66448.98% in 2022 and sank 41780.23% in 2025.
  • Over 5 years, Cash from Operations stood at -$83207.0 in 2022, then jumped by 70.39% to -$24636.0 in 2023, then plunged by 1985.36% to -$513750.0 in 2024, then slumped by 66.03% to -$852972.0 in 2025, then surged by 84.34% to -$133565.0 in 2026.
  • Per Business Quant data, the three most recent Cash from Operations figures were -$133565.0 in Q2 2026, $716175.0 in Q1 2026, and -$852972.0 in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Operations (Qtr)
1 Idexx Laboratories 40.69 Bn 40.49 Bn 779.09 Mn 347.16 Mn
2 Zoetis 30.63 Bn 28.95 Bn 1.05 Bn 655.00 Mn
3 Elanco Animal Health 11.77 Bn 11.24 Bn 798.00 Mn 277.00 Mn
4 Phibro Animal Health 1.49 Bn 1.41 Bn 134.40 Mn 24.09 Mn
5 Immucell 90.19 Mn 81.33 Mn 2.44 Mn -
6 Zhengye Biotechnology Holding 76.23 Mn 69.14 Mn - -
7 Global Innovative Platforms 24.88 Mn 24.63 Mn - -133,565.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -133,565.00
Mar 31, 2026 716,175.00
Dec 31, 2025 -852,972.00
Sep 30, 2025 -440,564.00
Jun 30, 2025 -184,273.00
Mar 31, 2025 202,144.00
Dec 31, 2024 -513,750.00
Sep 30, 2024 -348,028.00
Jun 30, 2024 -440.00
Mar 31, 2024 -2,589.00
Dec 31, 2023 -24,636.00
Sep 30, 2023 -129,866.00
Jun 30, 2023 -13,653.00
Mar 31, 2023 -61,589.00
Dec 31, 2022 -83,207.00
Sep 30, 2022 65,218.00
Jun 30, 2022 -11,500.00
Sep 30, 2021 98.00
Jun 30, 2021 51,168.00
Mar 31, 2021 -39,951.00